Cutaneous leishmaniasis in a Kosovan child treated with oral fluconazole

被引：11

作者：

Baron, S ^{[1
]}

Laube, S ^{[1
]}

Raafat, F ^{[1
]}

Moss, C ^{[1
]}

机构：

[1] Birmingham Childrens Hosp, Dept Dermatol & Histopathol, Birmingham B4 6NH, W Midlands, England

来源：

CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2004年 / 29卷 / 05期

关键词：

D O I：

10.1111/j.1365-2230.2004.01561.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：546 / 547

页数：3

共 9 条

[1] Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major [J].

Alrajhi, AA ;

Ibrahim, EA ;

De Vol, EB ;

Khairat, M ;

Faris, RM ;

Maguire, JH .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (12) :891-895

[2] Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator [J].

Arevalo, I ;

Ward, B ;

Miller, R ;

Meng, TC ;

Najar, E ;

Alvarez, E ;

Matlashewski, G ;

Llanos-Cuentas, A .

CLINICAL INFECTIOUS DISEASES, 2001, 33 (11) :1847-1851

[3] Leishmaniasis: new approaches to disease control [J].

Davies, CR ;

Kaye, P ;

Croft, SL ;

Sundar, S .

BRITISH MEDICAL JOURNAL, 2003, 326 (7385) :377-382

[4] Fluconazole for cutaneous leishmaniasis:: Looking for a better treatment [J].

González, U .

ARCHIVES OF DERMATOLOGY, 2002, 138 (12) :1604-1606

[5]

HALPERT E, 2000, TXB PAEDIAT DERMATOL, P514

[6] Leishmaniasis [J].

Herwaldt, BL .

LANCET, 1999, 354 (9185) :1191-1199

[7] Epidemiology of cutaneous leishmaniasis [J].

Klaus, SN ;

Frankenburg, S ;

Ingber, A .

CLINICS IN DERMATOLOGY, 1999, 17 (03) :257-260

[8]

*WHO, 2000, LEISHM HIV COINF SW

[9]

*WHO, 2000, 116 WHO

← 1 →